InvestSMART

Vita Life Sciences Limited (ASX:VLS)

ALERT: Price-sensitive ASX Announcement for VLS
Current share price for VLS : $2.570 0.17 (7.08%)+
Announcement
Release
12 Dec 2025 9:29AM
Price at Release
$2.400
Full Release
download
Summary
Vita Life Sciences Limited has provided its guidance for the financial year ending 31 December 2025, projecting sales between $91 million and $92 million, up from $79.5 million in FY2024. The pre-tax profit is expected to be between $13.2 million and $13.7 million, compared to $12.6 million in FY2024. Key growth areas include the Malaysian and Singaporean markets, expected to deliver a 30% revenue growth due to a strong brand presence and effective execution. The Australian market remains stable with continued positive contributions. However, export sales to China may fall short of expectations because of trade partner transitions and softer channel performance. The company continues to invest in brand development and marketing to support long-term growth, with emerging opportunities in Vietnam and China also being explored.
Key Points
  • FY2025 sales guidance: $91m-$92m (up from $79.5m in FY2024)
  • Pre-tax profit guidance: $13.2m-$13.7m (up from $12.6m in FY2024)
  • Strong performance expected in Malaysia and Singapore with 30% revenue growth
  • Australian market remains positive and stable
  • Export sales to China may underperform due to transition and channel issues
  • Ongoing investments in brand development and marketing
  • Focus on emerging opportunities in Vietnam and China
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.